Antibody-mediated Rejection of Kidney Transplant
📧 Sign up to get email alerts when something new happens for Antibody-mediated Rejection of Kidney Transplant.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Silymarin's Advantage on Graft Effectiveness [Phase 3]
Phase 3 clinical trial update indicating enrollment by invitation for Silymarin to improve graft effectiveness in transplant patients.
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: C1-Inhibitor (INH) for Refractory Antibody Mediated Renal Allograft Rejection [Phase 2]
Phase 2 trial update for C1-Inhibitor (INH) in refractory antibody-mediated rejection after kidney transplant; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Bortezomib in Late Antibody-mediated Kidney Transplant Rejection [Phase 2]
A Phase 2 trial evaluating bortezomib for late antibody-mediated rejection in renal transplant recipients has completed.